Qiagen N.V. (ETR:QIA)
40.47
-0.64 (-1.56%)
Oct 10, 2025, 5:35 PM CET
Qiagen Revenue
Qiagen had revenue of $533.54M USD in the quarter ending June 30, 2025, with 7.49% growth. This brings the company's revenue in the last twelve months to $2.04B, up 5.15% year-over-year. In the year 2024, Qiagen had annual revenue of $1.98B with 0.66% growth.
Revenue (ttm)
$2.04B
Revenue Growth
+5.15%
P/S Ratio
5.03
Revenue / Employee
$378.07K
Employees
5,396
Market Cap
8.74B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.98B | 12.90M | 0.66% |
Dec 31, 2023 | 1.97B | -176.21M | -8.23% |
Dec 31, 2022 | 2.14B | -110.14M | -4.89% |
Dec 31, 2021 | 2.25B | 381.31M | 20.39% |
Dec 31, 2020 | 1.87B | 343.92M | 22.53% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Siemens Healthineers AG | 23.38B |
Merck KGaA | 21.22B |
Bayer Aktiengesellschaft | 46.17B |
Fresenius SE & Co. KGaA | 22.28B |
Fresenius Medical Care AG | 19.52B |
Sartorius Aktiengesellschaft | 3.47B |
Fielmann Group AG | 2.40B |
Carl Zeiss Meditec AG | 2.18B |
Qiagen News
- 2 days ago - QGEN vs. ACAD: Which Stock Is the Better Value Option? - Nasdaq
- 9 days ago - Qiagen (QGEN) Analyst Maintains Rating But Lowers Price Target | QGEN Stock News - GuruFocus
- 16 days ago - Qiagen Breaks Below 200-Day Moving Average - Notable for QGEN - Nasdaq
- 16 days ago - Qiagen N.V. (QGEN) Presents at Bank of America Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 26 days ago - QGEN Stock Gains From CE-IVDR Certification for QIAstat-Dx Portfolio - Nasdaq
- 4 weeks ago - Qiagen (QGEN) Earns CE-IVDR Certification for Advanced Diagnostic Panels - GuruFocus
- 4 weeks ago - QIAGEN Secures European CE-IVDR Certification for Full QIAstat-Dx Portfolio - Wallstreet:Online
- 4 weeks ago - QIAGEN Secures European CE-IVDR Certification for Full QIAstat-Dx Portfolio - Business Wire